Sterile protection against human malaria by chemoattenuated PfSPZ vaccine B Mordmüller, G Surat, H Lagler, S Chakravarty, AS Ishizuka, ... Nature 542 (7642), 445-449, 2017 | 423 | 2017 |
First-in-human, randomized, double-blind clinical trial of differentially adjuvanted PAMVAC, a vaccine candidate to prevent pregnancy-associated malaria B Mordmüller, M Sulyok, D Egger-Adam, M Resende, WA de Jongh, ... Clinical Infectious Diseases 69 (9), 1509-1516, 2019 | 129 | 2019 |
Community movement and COVID-19: a global study using Google's Community Mobility Reports M Sulyok, M Walker Epidemiology & Infection 148, e284, 2020 | 111 | 2020 |
DSM265 for Plasmodium falciparum chemoprophylaxis: a randomised, double blinded, phase 1 trial with controlled human malaria infection M Sulyok, T Rückle, A Roth, RE Mürbeth, S Chalon, N Kerr, SS Samec, ... The Lancet Infectious Diseases 17 (6), 636-644, 2017 | 111 | 2017 |
Can Google Trends data improve forecasting of Lyme disease incidence? M Kapitány‐Fövény, T Ferenci, Z Sulyok, J Kegele, H Richter, ... Zoonoses and public health 66 (1), 101-107, 2019 | 43 | 2019 |
Heterologous protection against malaria by a simple chemoattenuated PfSPZ vaccine regimen in a randomized trial Z Sulyok, R Fendel, B Eder, FR Lorenz, N Kc, M Karnahl, A Lalremruata, ... Nature communications 12 (1), 2518, 2021 | 41 | 2021 |
Google Trends Data and COVID‐19 in Europe: Correlations and model enhancement are European wide M Sulyok, T Ferenci, M Walker Transboundary and Emerging Diseases 68 (4), 2610-2615, 2021 | 38 | 2021 |
Successful treatment of HCV-associated cryoglobulinemia with ombitasvir/paritaprevir/ritonavir, dasabuvir and ribavirin: a case report M Makara, M Sulyok, O Csacsovszki, Z Sulyok, I Vályi-Nagy Journal of Clinical Virology 72, 66-68, 2015 | 38 | 2015 |
Hepatic steatosis in individuals living with HIV measured by controlled attenuation parameter: a cross-sectional study M Sulyok, M Makara, Z Rupnik, T Ferenci, E Újhelyi, L Kormos, Z Gerlei, ... European journal of gastroenterology & hepatology 27 (6), 679-685, 2015 | 28 | 2015 |
Predicting tick-borne encephalitis using Google Trends M Sulyok, H Richter, Z Sulyok, M Kapitány-Fövény, MD Walker Ticks and tick-borne diseases 11 (1), 101306, 2020 | 27 | 2020 |
Ocular pentastomiasis in the Democratic Republic of the Congo M Sulyok, L Rózsa, I Bodó, D Tappe, R Hardi PLoS neglected tropical diseases 8 (7), e3041, 2014 | 26 | 2014 |
Co-infections in visceral pentastomiasis, Democratic Republic of the Congo D Tappe, M Sulyok, T Riu, L Rózsa, I Bodó, C Schoen, B Muntau, ... Emerging Infectious Diseases 22 (8), 1333, 2016 | 25 | 2016 |
A PfSPZ vaccine immunization regimen equally protective against homologous and heterologous controlled human malaria infection B Mordmüller, Z Sulyok, M Sulyok, Z Molnar, A Lalremruata, CL Calle, ... npj Vaccines 7 (1), 100, 2022 | 23 | 2022 |
Online behavioural patterns for Coronavirus disease 2019 (COVID-19) in the United Kingdom MD Walker, M Sulyok Epidemiology & Infection 148, e110, 2020 | 23 | 2020 |
Burden of serious fungal diseases in Hungary J Sinko, M Sulyok, DW Denning Mycoses 58, 29-33, 2015 | 21 | 2015 |
CD276 as a novel CAR NK‐92 therapeutic target for neuroblastoma S Grote, KCH Chan, C Baden, H Bösmüller, M Sulyok, L Frauenfeld, ... Advances in Cell and Gene Therapy 4 (1), e105, 2021 | 20 | 2021 |
Social markers of a pandemic: modeling the association between cultural norms and COVID-19 spread data M Kapitány-Fövény, M Sulyok Humanities and Social Sciences Communications 7 (1), 1-9, 2020 | 20 | 2020 |
Mobility and COVID-19 mortality across Scandinavia: A modeling study M Sulyok, MD Walker Travel medicine and infectious disease 41, 102039, 2021 | 16 | 2021 |
Non-Hodgkin lymphoma and hepatitis C: where we are and what next? M Sulyok, M Makara, E Újhelyi, I Vályi-Nagy Pathology & Oncology Research 21, 1-7, 2015 | 11 | 2015 |
Delirium in hospitalized COVID-19 patients: Predictors and implications for patient outcome V Wilke, M Sulyok, MI Stefanou, V Richter, B Bender, U Ernemann, ... PLoS One 17 (12), e0278214, 2022 | 10 | 2022 |